CTCVac

F&T collaborates in joint R&D projects to obtain regulatory approvals for veterinary bio-pharmaceuticals and has signed an OEM production agreement using vGMP facilities for industrial animal enhancement products.

Dongbang Co., Ltd.

Signed a joint R&D agreement for GOST-based veterinary infectious disease prevention vaccines, while conducting a joint research to enhance productivity in atrophic piglets.

Magna Investment

Magna invested in the Industrial Animal Enhancement Immune Probiotics Development Project. (2019 Magna Fresh Fund for the Agricultural and Food Sector)

Korea Science & Technology Holdings

Invested in the three exclusive licenses transferred from KRIBB and their applications in developing core technologies and in human and veterinary immune therapeutics.

Daedeok Venture Partners

Invested in the development of immune probiotics to enhance industrial animals and the development of active immunotherapies for humans. (invested in the 2023 Daejeon Startup Park)

Rising S Ventures

Invested in the development of immune probiotics to enhance industrial animals and the development of active immunotherapies for humans.
(2023 KSBJ-Rising Star & 2023 Rising Star VIP)